![BE](/sites/all/themes/wivisp/images/be_logo_color.png)
- Did you mean
- respiratory infection
Search results - 14 results
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
(until 3 months post-booster) were assessed. Anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD) antibody levels were followed over time (until 28 days after the ...
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.
infections can cause significant morbidity in cystic fibrosis (CF). The current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic could therefore have a serious impact on the health of ...
Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay.
Immunoglobulin A Immunoglobulin G Immunoglobulin M Neutralization Tests Nucleocapsid Proteins Roc Curve SARS-CoV-2 Spike Glycoprotein, Coronavirus Abstract: Large-scale serosurveillance of severe acute respiratory ...
The global response to the COVID-19 pandemic: how have immunology societies contributed?
Agents Betacoronavirus Community-Institutional Relations Coronavirus Infections COVID-19 COVID-19 Vaccines Global Health Humans International Cooperation Pandemics Patient Education as Topic Personal ...